Recital 7, Regulation (EU) 2024/1892

In forcesince 10 Jul 2024

It is therefore likely that no decision on the renewal of the approval of these active substances can be taken before the expiry of their respective approval periods on 30 September 2024, and given that the reasons for the delays in the renewal procedures are beyond the control of the respective applicants, the approval periods of those active substances should be extended in order to enable the completion of the assessments required and to finalise the respective procedures on renewal of approval.